Submission of Response to Proposal to Remove Andrographis Paniculata from the Therapeutic Goods (Permissible Ingredients) Determination
(8 May 2026)
Recommendations for Implementing the Traditional Chinese Medicine (TCM) –Related Provisions of the China–Australia Free Trade Agreement (ChAFTA)
(23 Feb 2026)
Submission for Review and Revise TGO 101 – Heavy Metals Limits in Herbal Pills,
Capsules and Tablets
(5 June 2025)
Submission to CMBA on the Updated Guideline for Patient Health Record
(1 April 2025)
CMIC Submission for Cang Er Zi – Xanthium Sibiricum Fruit
（12 Sep 2024）
CMIC Submission for Accessibility Issues by the Registered Chinese Medicine Practitioners
(17 June 2024)
CMIC Submission for CMBA’sPublic Consultation on Guidelines on Safe Chinese Herbal Medicine Practice and Guidelines on Infection Prevention and Control for Acupuncture and Related Practices
(1st March 2022)
Download full document
CMIC Submission for CMBA’s Agenda Items
(31 August 2021)
Download full document
CMIC Scheduling Submission for Amygdalin and HCM in 2021
(12 March 2021)
Download full document
Joint Application for Rescheduling of Processed Aconitum Carmichaelii Debxi
(4 November 2020)
Download full document
CMIC Scheduling Submission for Amygdalin and HCN 2020
(3 July 2020)
Download full document